The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider White Marvin L since year 2005.
The trader's CIK number is 1493324.
At the time of the last reporting, White Marvin L was the President and CEO of Aptevo Therapeutics Inc. .
(stock ticker symbol APVO).
See this page for all insider trading activities at Aptevo Therapeutics Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-05-20||APVO||Aptevo Therapeutics Inc.||Buy||30,000||.81||24,300|
|2019-05-14||APVO||Aptevo Therapeutics Inc.||Buy||10,000||.78||7,800|
|2018-12-04||APVO||Aptevo Therapeutics Inc.||Buy||10,000||2.38||23,800|
|2018-05-21||APVO||Aptevo Therapeutics Inc.||Option Ex||35,644||.00||0|
|2018-03-19||APVO||Aptevo Therapeutics Inc.||Sale||100,000||2.93||293,000|
|2017-05-22||APVO||Aptevo Therapeutics Inc.||Option Ex||53,471||.00||0|
|2016-03-07||EBS||Emergent Biosolutions Inc.||Option Ex||33,134||17.42||577,326|
|2016-03-07||EBS||Emergent Biosolutions Inc.||Sale||33,134||35.42||1,173,606|
|2015-06-19||WPG||Washington Prime Group Inc.||Buy||1,500||14.30||21,450|
|2015-06-22||WPG||Washington Prime Group Inc.||Buy||3,500||14.20||49,700|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by White Marvin L (President and CEO of Aptevo Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.